bioRxivCancer BiologyPreprint
Glutamine-dependent downregulation of FLT3-ITD is a mechanism of FLT3 inhibitor resistance in FLT3-ITD AML in hypoxia
Giovannino SilvestriiD, Aditi ChatterjeeiD, Blair P. Rendina, Eli E. BariD, Maria R. BaeriD
Abstract
FLT3 inhibitors have improved outcomes in acute myeloid leukemia (AML) with FMS-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD), but responses are not durable. Notably, FLT3 inhibitors clear blasts from the blood, but not the bone marrow, a hypoxic niche. We investigated effects of hypoxia and the key nutrient glutamine on FLT3 inhibitor response. FLT3-ITD AML cell lines and patient blasts were cultured with FLT3 inhibitors under normoxia (21%) or hypoxia ( View larger version (52K): org.highwire.dtl.DTLVardef@1746bf8org.highwire.dtl.DTLVardef@5c9cdeorg.highwire.dtl.DTLVardef@3ee12aorg.highwire.dtl.DTLVardef@30c90c_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: bulk RNA-seq
- research focus: cancer & tumor microenvironment
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Ribonucleotide Reductase Inhibition Overcomes FLT3 Inhibitor Resistance in Acute Myeloid Leukemia
Zhen Tian, Xiaoyu Wei, … Jian Yuan Huang·bioRxiv·Jul 22, 2026
- Momelotinib is a highly potent inhibitor of FLT3-mutant AML
M. Azhar, Z. Kincaid, … M. Azam·bioRxiv·Mar 18, 2021
- Adaptive resistance to FLT3 inhibitors is potentiated by ROS-driven DNA repair signalling
Dilana Elisabeth Staudt, Zacary P. Germon, … Matthew D. Dun·bioRxiv·Jul 26, 2024
- Classes of ITD predict outcomes in patients with AML treated with FLT3 inhibitors
G. W. Schwartz, B. Manning, … R. Faryabi·bioRxiv·May 14, 2018
- Reprogramming of serine metabolism is an actionable vulnerability in FLT3-ITD driven acute myeloid leukaemia
S. Bjelosevic, E. Gruber, … R. W. Johnstone·Cancer DiscoveryPeer-reviewed·Jan 12, 2021
- Uncovering pre-sensitizing agents to FLT3 inhibitors in acute myeloid leukemia with ReSisTrace lineage tracing
Johanna Eriksson, Shuyu Zheng, … Jing Ping Tang·Cancer ResearchPeer-reviewed·Nov 21, 2025